Cargando…

Depletion of γ-catenin by Histone Deacetylase Inhibition Confers Elimination of CML Stem Cells in Combination with Imatinib

Quiescent leukemia stem cells (LSCs) that are insensitive to BCR-ABL tyrosine kinase inhibitors confer resistance to imatinib in chronic myelogenous leukemia (CML). Identifying proteins to regulate survival and stemness of LSCs is urgently needed. Although histone deacetylase inhibitors (HDACis) can...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Yanli, Yao, Yiwu, Chen, Li, Zhu, Xiaohui, Jin, Bei, Shen, Yingying, Li, Juan, Du, Xin, Lu, Yuhong, Jiang, Sheng, Pan, Jingxuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997248/
https://www.ncbi.nlm.nih.gov/pubmed/27570562
http://dx.doi.org/10.7150/thno.16139